{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:50:43Z","timestamp":1789041043013,"version":"build-2803163510"},"reference-count":50,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2025,1,23]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Chimeric antigen receptor (CAR) T cell therapy is a promising form of adoptive cell therapy. This process re-engineers patient-derived T cells to express a hybrid receptor targeting a selected tumour-expressed antigen. CAR T cell therapy directed against the CD19 antigen has been highly successful in haematological malignancies that have failed other therapies, particularly relapsed B-cell acute lymphoblastic leukaemia (B-ALL). This review focuses on the numerous real-world aspects of treating children with B-ALL with CD19-targeted CAR T cell therapy. We discuss some of the considerations for clinicians including manufacturing time, administration and care of the patient receiving this novel therapy, toxicities and outcomes. We also discuss the therapeutic uncertainty many physicians now face of when to use CAR T cell therapy in the patient journey, especially when haematopoietic stem cell transplant is being considered.<\/jats:p>","DOI":"10.1136\/archdischild-2024-328263","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T10:20:15Z","timestamp":1738837215000},"page":"503-509","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Chimeric antigen receptor T cell therapy in childhood leukaemia"],"prefix":"10.1136","volume":"110","clinical-trial-number":[{"clinical-trial-number":"nct02435849","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02435849","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5476-9323","authenticated-orcid":false,"given":"Stacie Shiqi","family":"Wang","sequence":"first","affiliation":[{"name":"Children's Cancer Centre, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0897-7874","authenticated-orcid":false,"given":"Rebecca C","family":"Abbott","sequence":"additional","affiliation":[{"name":"Centre of Excellence in Cellular Immunotherapy, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddie","family":"Gilsenan","sequence":"additional","affiliation":[{"name":"Children's Cancer Centre, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4637-1416","authenticated-orcid":false,"given":"Trevor","family":"Duke","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Department of Paediatrics, Royal Children's Hospital, The University of Melbourne, Parkville, Victoria, Australia"},{"name":"Child Health, School of Medicine and Health Sciences, University of Papua New Guinea, Port Moresby, National Capital District, Papua New Guinea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9084-8974","authenticated-orcid":false,"given":"Seong Lin","family":"Khaw","sequence":"additional","affiliation":[{"name":"Children's Cancer Centre, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"2025063004200808000_110.7.503.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21442"},{"key":"2025063004200808000_110.7.503.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70580-6"},{"key":"2025063004200808000_110.7.503.3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160310","article-title":"Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy","volume":"11","author":"Ceppi","year":"2016","journal-title":"PLoS ONE"},{"key":"2025063004200808000_110.7.503.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"2025063004200808000_110.7.503.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"2025063004200808000_110.7.503.6","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14076"},{"key":"2025063004200808000_110.7.503.7","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0548"},{"key":"2025063004200808000_110.7.503.8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.2.720"},{"key":"2025063004200808000_110.7.503.9","doi-asserted-by":"publisher","DOI":"10.1038\/mto.2016.15"},{"key":"2025063004200808000_110.7.503.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2016.12.006"},{"key":"2025063004200808000_110.7.503.11","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003092"},{"key":"2025063004200808000_110.7.503.12","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00238-6"},{"key":"2025063004200808000_110.7.503.13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006035"},{"key":"2025063004200808000_110.7.503.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00754-1"},{"key":"2025063004200808000_110.7.503.15","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0095"},{"key":"2025063004200808000_110.7.503.16","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0442"},{"key":"2025063004200808000_110.7.503.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0184-6"},{"key":"2025063004200808000_110.7.503.18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016937"},{"key":"2025063004200808000_110.7.503.19","doi-asserted-by":"crossref","unstructured":"Gupta S , Rau RE , Kairalla JA , et al . Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children. N Engl J Med 2024. doi:10.1056\/NEJMoa2411680","DOI":"10.1056\/NEJMoa2411680"},{"key":"2025063004200808000_110.7.503.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-00456-y"},{"key":"2025063004200808000_110.7.503.21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1200\/JCO.20.01616","article-title":"How I Manage: Pathophysiology and Management of Toxicity of Chimeric Antigen Receptor T-Cell Therapies","volume":"39","author":"Reagan","year":"2021","journal-title":"J Clin Oncol"},{"key":"2025063004200808000_110.7.503.22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-793760"},{"key":"2025063004200808000_110.7.503.23","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004000"},{"key":"2025063004200808000_110.7.503.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-793141"},{"key":"2025063004200808000_110.7.503.25","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood.2019001463","article-title":"Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy","volume":"134","author":"Gardner","year":"2019","journal-title":"Blood"},{"key":"2025063004200808000_110.7.503.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00547-6"},{"key":"2025063004200808000_110.7.503.27","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017414"},{"key":"2025063004200808000_110.7.503.28","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002757"},{"key":"2025063004200808000_110.7.503.29","article-title":"Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome","volume":"29","author":"Hines","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"2025063004200808000_110.7.503.30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-12-893396"},{"key":"2025063004200808000_110.7.503.31","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0582-9"},{"key":"2025063004200808000_110.7.503.32","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood.2024023933","article-title":"Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents","volume":"144","author":"Diorio","year":"2024","journal-title":"Blood"},{"key":"2025063004200808000_110.7.503.33","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19015"},{"key":"2025063004200808000_110.7.503.34","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20202"},{"key":"2025063004200808000_110.7.503.35","unstructured":"EMA . KYMRIAH: EPAR - product information. 2018. Available: https:\/\/www.ema.europa.eu\/en\/documents\/product-information \/kymriah-epar-product-information_en.pdf"},{"key":"2025063004200808000_110.7.503.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-015-2027-x"},{"key":"2025063004200808000_110.7.503.37","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15012"},{"key":"2025063004200808000_110.7.503.38","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020578"},{"key":"2025063004200808000_110.7.503.39","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa121","article-title":"Infectious Complications Following CD19 Chimeric Antigen Receptor T-cell Therapy for Children, Adolescents, and Young Adults","volume":"7","author":"Vora","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025063004200808000_110.7.503.40","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14202","article-title":"Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia","volume":"25","author":"Diamond","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"2025063004200808000_110.7.503.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.05.014"},{"key":"2025063004200808000_110.7.503.42","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001159","article-title":"Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies","volume":"8","author":"Shalabi","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2025063004200808000_110.7.503.43","doi-asserted-by":"publisher","DOI":"10.1002\/pon.5674"},{"key":"2025063004200808000_110.7.503.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01981-8"},{"key":"2025063004200808000_110.7.503.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01281-7"},{"key":"2025063004200808000_110.7.503.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198106183042507"},{"key":"2025063004200808000_110.7.503.47","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02529"},{"key":"2025063004200808000_110.7.503.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0806-8"},{"key":"2025063004200808000_110.7.503.49","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0297"},{"key":"2025063004200808000_110.7.503.50","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402552"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2024-328263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T11:20:37Z","timestamp":1751282437000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2024-328263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,6,19]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/archdischild-2024-328263"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2024-328263","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]}}}